Adenosine acting on A1 receptors protects NO-triggered rebound potentiation and LTP in rat hippocampal slices

Journal of Neurophysiology
C L Bon, John Garthwaite

Abstract

Exposure of hippocampal slices to nitric oxide (NO) results in a depression of CA1 synaptic transmission. Under 0.2-Hz stimulation, washout of NO leads to a persistent potentiation that depends on N-methyl-D-aspartate (NMDA) receptors and endogenous NO formation and that occludes tetanus-induced long-term potentiation (LTP). The experiments were initially aimed at determining the relationship between the NO-induced synaptic depression and rebound potentiation. The adenosine A1 antagonist, 8-cyclopentyl-1,3-dipropylxanthine (DPCPX) partially inhibited the depression produced by the NO donor diethylamine NONOate (300 microM). It also led to a complete block of both the rebound potentiation and the subsequent tetanus-induced LTP. LTP was preserved in the presence of DPCPX if the stimulation frequency was reduced to 0.033 Hz or if the NO application was omitted. The NO-triggered rebound potentiation was restored if the experiment (DPCPX followed by exogenous NO) was conducted in the presence of an NMDA antagonist. The restored potentiation was completely blocked by the NO synthase inhibitor, L-nitroarginine. It is concluded that the NO-induced depression is partially mediated by increased release of endogenous adenosine acting on A...Continue Reading

References

Nov 24, 1978·Brain Research·B L McNaughtonG V Goddard
May 15, 1991·Biochemical and Biophysical Research Communications·M A DwyerS H Snyder
Jul 9, 1991·European Journal of Pharmacology·G A BöhmeJ C Blanchard
Oct 2, 1990·Neuroscience Letters·A de Mendonça, J A Ribeiro
Oct 23, 1989·Neuroscience Letters·E J CoanG L Collingridge
Mar 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·B H Gähwiler, D A Brown
May 1, 1980·British Journal of Pharmacology·T V Dunwiddie, B J Hoffer
Jan 1, 1995·Annual Review of Physiology·J Garthwaite, C L Boulton
Oct 1, 1994·The European Journal of Neuroscience·C L BoultonG L Collingridge
Dec 1, 1993·The Journal of Physiology·C H Davies, G L Collingridge
May 1, 1993·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·T MalinskiM Chopp
Jul 1, 1996·Journal of Neurochemistry·N FallahiB B Fredholm
Apr 1, 1997·The European Journal of Neuroscience·J Rodriguez-AlvarezJ Bockaert
Jun 1, 1997·Current Opinion in Neurobiology·J E Brenman, D S Bredt
Jan 15, 1998·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Y IzumiC F Zorumski
Sep 15, 1998·Trends in Neurosciences·H DanielF Crépel
Feb 5, 1999·Progress in Brain Research·R D HawkinsO Arancio
Feb 5, 1999·Progress in Brain Research·C F Zorumski, Y Izumi
May 13, 1999·Biochimica Et Biophysica Acta·G C Brown
Mar 23, 2000·Progress in Neurobiology·P CalabresiG Bernardi
Jan 1, 1992·The European Journal of Neuroscience·Christelle BonJean-Charles Blanchard

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.